SYNLAB AG (VIE: SYAB)

Market Cap	2.48B
Revenue (ttm)	2.62B
Net Income (ttm)	89.35M
Shares Out	n/a
EPS (ttm)	0.40
PE Ratio	27.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	12
Open	11.20
Previous Close	11.30
Day's Range	11.20 - 11.30
52-Week Range	10.14 - 12.30
Beta	n/a
RSI	48.93
Earnings Date	Mar 14, 2025

About SYNLAB AG

SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers medical and veterinary diagnostics services. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.

• Industry: Medical Laboratories
• Founded: 1998
• Employees: 23,538
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: SYAB

Financial Performance

In 2023, SYNLAB AG's revenue was 2.64 billion, a decrease of -18.93% compared to the previous year's 3.25 billion. Earnings were 92.27 million, a decrease of -38.77%.